Results 71 to 80 of about 132,280 (264)
Heterogeneous lupus‐specific lesions and treatment outcome, in a single patient, over a period of time [PDF]
, 2019 The report highlights the importance of strict clinico-histological correlations when skin biopsies are performed in diagnostic doubt in systemic lupus erythematosus.
Agostini, Patrick +5 more
core +2 more sources
A randomized, placebo‐controlled trial of hydroxychloroquine in incomplete lupus
Arthritis &Rheumatology, Accepted Article.Objectives Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity and incidence of SLE. Methods Hydroxychloroquine (HCQ) was chosen as an
Nancy J. Olsen +14 more
wiley +1 more source
Low Dose Thalidomide for Treatment of Resistant Discoid Lupus Erythematosus. A Case Report [PDF]
, 2013 Discoid lupus erythematosus (DLE) is a chronic, indolent, disfiguring disease that is characterized by scaly, erythematous, disk-shaped patches and plaques followed by atrophy, scarring and depigmentation.
Campos, S, Lestre, S, Ponte, P
core
British Journal of Clinical Pharmacology, EarlyView.Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Arthritis & Rheumatology, 2017 Interferon‐γ (IFNγ) is implicated in the pathogenesis of discoid lupus erythematosus (DLE). This study sought to evaluate a single dose of AMG 811, an anti‐IFNγ antibody, in patients with DLE.
V. Werth +12 more
semanticscholar +1 more source
Barnes Hospital Bulletin [PDF]
, 1976 https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1125/thumbnail ...
core +1 more source
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and Objectives Pemphigoid diseases are primarily mediated by IgG or IgA autoantibodies against the cutaneous basement membrane zone (BMZ). Although recent observations suggest the existence of exclusively IgM‐mediated pemphigoid disease, a larger study is lacking.
Kaan Yilmaz +15 more
wiley +1 more source
Efalizumab in the Treatment of Discoid Lupus Erythematosus [PDF]
Archives of Dermatology, 2007 Discoid lupus erythematosus is a chronic inflammatory condition in which the pathogenesis and the role of cell-mediated immunity remains unclear. Currently, the most effective treatments for severe disease are thalidomide, methotrexate, and cyclosporin, although the evidence for this is limited.
Naila Usmani, Mark Goodfield
openaire +2 more sources
Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan [PDF]
, 2010 We investigated Patients with systemic lupus erythematosus with the objective of assessing whether early damage accrued in systemic lupus erythematosus as measured by the SLICC/ACR Damage Index predicts mortality in lupus Patients that have been followed
Ahmad, A. +7 more
core +1 more source
Vulgar psoriasis and squamous cell carcinoma in a patient with discoid lupus erythematosus
Vestnik Dermatologii i Venerologii, 2020 A rare case of a combination of vulgar psoriasis and squamous cell carcinoma of the penis in a patient with discoid lupus erythematosus is described. The literature data on the comorbidity of dermatoses are given.
Valeriy V. Dubensky +3 more
doaj +1 more source